Healthcare

What do you know about aortic valve stenosis?

Aortic valve stenosis (AVS) is a degenerative disease that causes a narrowing of the heart’s aortic valve. This narrowing prevents the valve from opening fully, which obstructs the blood flow from the heart to the aorta and the rest of the body causing symptoms that, at advanced stages, can be life-threatening. Different treatments are available for this disease. In order to decide on the best therapeutic strategy for each patient, the MITMEVA project was launched.  This is a project carried out by the Hospital Clínic Cardiovascular Institute.

Aortic valve stenosis (AVS) is a degenerative disease that causes a narrowing of the heart’s aortic valve.

The main aim of this proposal is to improve the quality and efficiency of the clinical management of patients with AVS, candidates for aortic valve replacement by surgical or percutaneous means (TAVI), or else for symptomatic medical treatment.  This programme is also designed to optimise the available resources with a new integrated, crosscutting and multidisciplinary healthcare model (MITMEVA).

The Hospital Clínic Cardiovascular Institute has published a short webinar in order to explain aortic valve stenosis in simple terms, allowing it to be understood by all audiences.  

The MITMEVA project also wants to find out what the general public knows about this disease. Use this form to test yourself. It’s very easy! Answer the survey.